ENTITY
Paradigm Biopharmaceuticals

Paradigm Biopharmaceuticals (PAR AU)

19
Analysis
Health CareAustralia
Paradigm Biopharmaceuticals Limited operates as a biopharmaceutical company. The Company develops PPS drug to treat respiratory diseases such as allergic asthma, allergic rhinitis, and chronic obstructive pulmonary. Paradigm Biopharmaceuticals offers its services in Australia.
more
Refresh
Publication Icon
No publications yet
There aren’t any buy-side reports right now
Back to "All"
x